| 0900 - 0910 |
|
Opening remarks |
|
Jeremy YC TEOH |
|
|
SESSION I - KIDNEY CANCER & UTUC |
|
|
| 0910 - 0930 |
|
AI and biomarkers for personalized care in renal cell carcinoma |
|
David KW LEUNG |
| 1030 - 1100 |
|
Plan, prevent, salvage: Haemostatic strategies in challenging kidney surgeries |
|
Francis CH WONG |
| 0950 - 1010 |
|
Renal tumor with advanced IVC thrombus: The different approaches |
|
Samuel CH YEE |
| 1010 - 1030 |
|
Stereotactic body radiotherapy for primary renal cell carcinoma |
|
Darren MC POON |
| 1030 - 1100 |
|
Tea break |
|
|
|
|
SESSION II - Bladder Cancer |
|
|
| 1100 - 1120 |
|
Risk stratification of intermediate-risk NMIBC and its clinical implications |
|
Chris HM WONG |
| 1120 - 1140 |
|
Immunotherapy for BCG-naive High-risk NMIBC: What's new in 2026? |
|
Wei Chong TAN |
| 1140 - 1200 |
|
Novel intravesical drug delivery system for BCG-unresponsive NMIBC |
|
Jeremy YC TEOH |
| 1200 - 1220 |
|
En bloc radical cystectomy: What, why and how? |
|
Laura BUKAVINA |
|
|
Lunch Symposium |
|
|
| 1220 - 1250 |
|
Emerging immunotherapy-based treatment in early stage RCC and MIBC |
|
Shilpa GUPTA |
| 1250 - 1330 |
|
Lunch |
|
|
|
|
SESSION III - Prostate Cancer |
|
|
| 1330 - 1450 |
|
Building the blueprint for modern mHSPC care |
|
Derya TILKI |
| 1350 - 1410 |
|
Precision medicine of prostate cancer |
|
TBC |
| 1410 - 1430 |
|
Advancing early action: Optimizing treatment strategies in non-metastatic hormone-sensitive prostate cancer |
|
Edmund CHIONG |
| 1430 - 1450 |
|
Radioligand therapy and ARPI in mCRPC - Competition or combination? |
|
Clifford JH HONG |
|
|
SESSION IV - Hot Topics in Urological Cancers |
|
|
| 1450 - 1510 |
|
The current evidence and clinical utility of ctDNA in urothelial cancer |
|
Laura BUKAVINA |
| 1510 - 1530 |
|
Histotripsy for intra-abdominal solid organ tumours: The future is here |
|
Neeraj MAHBOOBANI |
| 1530 - 1550 |
|
Robotic high-intensity focused ultrasound: New kid on the block |
|
Peter KF CHIU |
| 1550 - 1610 |
|
Retzius-sparing robotic prostatectomy: What have I learnt over the past 100 cases |
|
Joe CC NGO |
| 1610 - 1615 |
|
Closing remarks |
|
Peter KF CHIU |
